BR9502704A - Tablete cápsula ou granulo para administração oral contendo desogestrel e processo para incorporação de um desogestrel e opcionalmente um estrogenio em um solido - Google Patents

Tablete cápsula ou granulo para administração oral contendo desogestrel e processo para incorporação de um desogestrel e opcionalmente um estrogenio em um solido

Info

Publication number: BR9502704A
Authority: BR; Brazil
Prior art keywords: desogestrel; capsule; oral administration; solid; estrogen
Prior art date: 1994-06-08

Application number

BR9502704A

Other languages

English (en)

Inventor

Pieter Haan

Johannes Gerardus Jos Egberink

Original Assignee

Akzo Nobel Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-06-08

Filing date

1995-06-07

Publication date

1996-03-05

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8216929&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9502704(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1995-06-07 Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv

1996-03-05 Publication of BR9502704A publication Critical patent/BR9502704A/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Organic Chemistry (AREA)
Endocrinology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Diabetes (AREA)
Gynecology & Obstetrics (AREA)
Reproductive Health (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

BR9502704A 1994-06-08 1995-06-07 Tablete cápsula ou granulo para administração oral contendo desogestrel e processo para incorporação de um desogestrel e opcionalmente um estrogenio em um solido BR9502704A (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP94201625		1994-06-08

Publications (1)

Publication Number	Publication Date
BR9502704A true BR9502704A (pt)	1996-03-05

Family

ID=8216929

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BR9502704A BR9502704A (pt)	1994-06-08	1995-06-07	Tablete cápsula ou granulo para administração oral contendo desogestrel e processo para incorporação de um desogestrel e opcionalmente um estrogenio em um solido

Country Status (18)

Country	Link
US (1)	US5709881A (pt)
EP (1)	EP0688565B2 (pt)
JP (1)	JP4302783B2 (pt)
KR (1)	KR100380841B1 (pt)
CN (1)	CN1057673C (pt)
AT (1)	ATE254921T1 (pt)
AU (1)	AU697512B2 (pt)
BR (1)	BR9502704A (pt)
CA (1)	CA2150642C (pt)
DE (1)	DE69532176T3 (pt)
DK (1)	DK0688565T4 (pt)
ES (1)	ES2210272T5 (pt)
FI (1)	FI952765L (pt)
HU (1)	HU218282B (pt)
IL (1)	IL113816A (pt)
NZ (1)	NZ272285A (pt)
PT (1)	PT688565E (pt)
RU (1)	RU2160107C2 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6756366B1 (en) *	1999-04-06	2004-06-29	Akzo Nobel N.V.	Orally active androgens
DK1204410T3 (da) *	1999-07-30	2012-10-29	Capsugel Belgium Nv	Farmaceutisk doseringsform med flere komponenter
CN101961317A (zh) *	2001-07-06	2011-02-02	生命周期药物公司	受控制的凝聚
TW200403075A (en) *	2002-05-29	2004-03-01	Akzo Nobel Nv	Progestagenic dosage units
CN105030792B (zh) *	2015-06-30	2017-08-25	上海交通大学	Desogestrel在制备抗结肠癌/ER阴性的Ah受体阳性的乳腺癌产品中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS56140915A (en) †	1980-04-07	1981-11-04	Yamanouchi Pharmaceut Co Ltd	Pharmaceutical preparation for solid drug
DE3421468A1 (de) *	1984-06-08	1985-12-19	Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim	Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung
ES2024010B3 (es)	1987-07-06	1992-02-16	Akzo Nv	Unidad de dosis farmaceutica.
EP0368373A1 (en) *	1988-10-13	1990-05-16	Akzo Nobel N.V.	Multi-phase contraceptive preparation
US4948593A (en) *	1989-05-15	1990-08-14	Alza Corporation	Osmotic dosage form comprising an estrogen and a progestogen
US5395627A (en) †	1992-09-04	1995-03-07	Akzo N.V.	Pharmaceutical granulate

1995
- 1995-05-22 IL IL11381695A patent/IL113816A/en not_active IP Right Cessation
- 1995-05-31 CA CA002150642A patent/CA2150642C/en not_active Expired - Fee Related
- 1995-06-06 AU AU20531/95A patent/AU697512B2/en not_active Ceased
- 1995-06-06 NZ NZ272285A patent/NZ272285A/en not_active IP Right Cessation
- 1995-06-06 FI FI952765A patent/FI952765L/fi not_active Application Discontinuation
- 1995-06-07 DE DE69532176T patent/DE69532176T3/de not_active Expired - Fee Related
- 1995-06-07 HU HU9501654A patent/HU218282B/hu not_active IP Right Cessation
- 1995-06-07 RU RU95109859/14A patent/RU2160107C2/ru not_active IP Right Cessation
- 1995-06-07 CN CN95107349A patent/CN1057673C/zh not_active Expired - Fee Related
- 1995-06-07 KR KR1019950014913A patent/KR100380841B1/ko not_active Expired - Fee Related
- 1995-06-07 ES ES95201495T patent/ES2210272T5/es not_active Expired - Lifetime
- 1995-06-07 EP EP95201495A patent/EP0688565B2/en not_active Expired - Lifetime
- 1995-06-07 PT PT95201495T patent/PT688565E/pt unknown
- 1995-06-07 AT AT95201495T patent/ATE254921T1/de not_active IP Right Cessation
- 1995-06-07 BR BR9502704A patent/BR9502704A/pt not_active IP Right Cessation
- 1995-06-07 DK DK95201495T patent/DK0688565T4/da active
- 1995-06-08 JP JP14176895A patent/JP4302783B2/ja not_active Expired - Fee Related
1997
- 1997-05-28 US US08/864,435 patent/US5709881A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
DE69532176T2 (de)	2004-08-12
ES2210272T3 (es)	2004-07-01
PT688565E (pt)	2004-03-31
NZ272285A (en)	1996-08-27
JPH07330610A (ja)	1995-12-19
CA2150642A1 (en)	1995-12-09
FI952765A0 (fi)	1995-06-06
JP4302783B2 (ja)	2009-07-29
ATE254921T1 (de)	2003-12-15
DK0688565T3 (da)	2004-03-29
EP0688565A1 (en)	1995-12-27
ES2210272T5 (es)	2008-05-01
AU697512B2 (en)	1998-10-08
HK1001996A1 (en)	1998-07-24
CN1122226A (zh)	1996-05-15
HU218282B (en)	2000-07-28
CA2150642C (en)	2008-04-22
FI952765A7 (fi)	1995-12-09
DK0688565T4 (da)	2008-03-17
FI952765L (fi)	1995-12-09
HU9501654D0 (en)	1995-07-28
IL113816A (en)	1998-12-06
US5709881A (en)	1998-01-20
HUT71491A (en)	1995-11-28
CN1057673C (zh)	2000-10-25
DE69532176D1 (de)	2004-01-08
DE69532176T3 (de)	2008-06-12
AU2053195A (en)	1995-12-14
RU2160107C2 (ru)	2000-12-10
IL113816A0 (en)	1995-08-31
KR960000231A (ko)	1996-01-25
EP0688565B1 (en)	2003-11-26
KR100380841B1 (ko)	2003-08-14
EP0688565B2 (en)	2007-11-21

Similar Documents

Publication	Publication Date	Title
DK588487A (da)	1988-05-29	Forbedrede metalholdige farmaceutiske midler
DE69014351D1 (de)	1995-01-12	Pyridincarbonsäureamid-Derivate und diese enthaltende pharmazeutische Zusammensetzungen.
FR2777784B1 (fr)	2004-03-19	Composition pharmaceutique a base d'estrogene et de progesterone
DE3750913D1 (de)	1995-02-09	Karbostyrilderivate, Verfahren zu ihrer Herstellung, diese enthaltende pharmazeutische Zusammensetzungen und ihre Verwendung.
DE3852145D1 (de)	1995-01-05	Indolderivate, Verfahren zu deren Herstellung und pharmazeutische Präparate, die diese enthalten.
DE69008566D1 (de)	1994-06-09	Pyridazin-Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen.
DE3777122D1 (de)	1992-04-09	Alkansulfonanilid-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE211745T1 (de)	2002-01-15	10,13,15-trioxatricyclo(9.2.1.1. 9.6)- pentadecanon-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
BR9502704A (pt)	1996-03-05	Tablete cápsula ou granulo para administração oral contendo desogestrel e processo para incorporação de um desogestrel e opcionalmente um estrogenio em um solido
ATE70973T1 (de)	1992-01-15	Heterocyclische sulfide, verfahren zu ihrer herstellung und pharmazeutische mittel, die diese verbindungen enthalten.
DE3767894D1 (de)	1991-03-14	1,2-dithiol-3-thion-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellung.
DE58904595D1 (de)	1993-07-15	Neue alkylphosphonoserine, verfahren zu deren herstellung und diese enthaltende pharmazeutische mittel.
DE69004188D1 (de)	1993-12-02	Carboxylatverbindungen, diese Verbindungen enthaltende flüssigkristalline Zusammensetzungen und flüssigkristalliner Bauteil.
DE69019807D1 (de)	1995-07-06	Pyrimidindionderivate, Verfahren zu deren Herstellung und diese enthaltende antiarrhythmische Mittel.
NO923266L (no)	1993-02-22	Heksahydrobenzo(f)quinolinoner
DE69012742D1 (de)	1994-10-27	Azolderivate und fungizide Medikamente, diese als wirkende Komponente enthaltend.
ATE58293T1 (de)	1990-11-15	Heterocyclische disulfide, verfahren zu ihrer herstellung und pharmazeutische mittel, die diese verbindungen enthalten.
DE69105848D1 (de)	1995-01-26	2-Diazo-1,2-chinonverbindungen und Reproduktionsmaterialien, die diese Verbindungen enthalten.
FR2694292B1 (fr)	1994-10-21	Dérivés de benzimidazole-2-thione-, leur préparation et leur application en tant que médicament.
FR2703908B1 (fr)	1995-06-02	Forme pharmaceutique pour administration rectale de composés pharmacologiquement actifs.
DE3787319D1 (de)	1993-10-14	1,4-Dihydropyridin-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen.
DK379287A (da)	1988-01-23	1,3-propandiaminderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende disse
DE69006653D1 (de)	1994-03-24	Alpha-hydroxyketonabkömmlinge, diese Abkömmlinge enthaltende Flüssigkristallzusammensetzungen und diese Zusammensetzungen anwendende Flüssigkristallgeräte.
ATE68479T1 (de)	1991-11-15	Aminopropanolderivate von 3-(3'-hydroxyphenyl)-1- propanon-verbindungen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
ATE50995T1 (de)	1990-03-15	3,4-dihydrobenzopyranverbindungen und diese enthaltende pharmazeutische zusammenstellungen.

Legal Events

Date	Code	Title	Description
2001-09-25	FB36	Technical and formal requirements: requirement - article 36 of industrial property law
2002-03-12	HJEG	Technical examination (opinion): technical examination (opinion) related to article 229 of industrial property law
2002-12-17	FF	Decision: intention to grant
2003-04-01	FG9A	Patent or certificate of addition granted
2010-05-18	B24C	Patent annual fee: request for for restoration	Free format text: REFERENTE A 15A ANUI DADE.
2012-01-17	B21F	Lapse acc. art. 78, item iv - on non-payment of the annual fees in time	Free format text: REFERENTE AO NAO CUMPRIMENTO DO DESPACHO PUBLICADO NA RPI 2054 DE 18/05/2010 E AO NAO RECOLHIMENTO DA 16A ANUIDADE.